Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/29655
Başlık: Apoptosis-inducing effect of a palladium(II) complex-[PdCl(terpy)](sac)center dot 2H2O] on ehrlich ascites carcinoma (EAC) in mice
Yazarlar: İkitimur, Elif I. Armutak
Gürel, Ebru Gürevin
Yaylım, İlhan
İşbilen, Banu Başok
Şennazlı, Gülbin
Yüzbaşıoğlu, Gülay Öztürk
Sönmez, Kıvılcım
Çelik, Faruk
Küçükhüseyin, Özlem
Korkmaz, Gurbet
Zeybek, Şakir Ümit
Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyokimya Anabilim Dalı.
Uludağ Üniversitesi/Fen-Edebiyat Fakültesi/Kimya Bölümü.
0000-0002-2849-3332
Ulukaya, Engin
Yılmaz, Veysel T.
K-5792-2018
L-7238-2018
6602927353
56441123900
Anahtar kelimeler: Research & experimental medicine
Pd(II) complex
EAC
Breast cancer
Apoptosis
In vivo
Breast-cancer cells
Nuclear antigen immunohistochemistry
Gene bax-alpha
Insulin-receptor substrate-1
Saccharinate complex
In-vitro
Tumor-growth
Death
Phosphorylation
Terpyridine
Yayın Tarihi: 28-Nis-2016
Yayıncı: Int Inst Anticancer Research
Atıf: İkitimur, A. E. I. vd. (2016). "Apoptosis-inducing effect of a palladium(II) complex-[PdCl(terpy)](sac)center dot 2H2O] on ehrlich ascites carcinoma (EAC) in mice". In Vivo, 30(4), 457-464.
Özet: Background/Aim: New compounds for cancer treatment are needed due to persistenly unsatisfactory management of cancer. [PdCl(terpy)](sac)center dot 2H2O] (sac= saccharinate, and terpy= 2,2':6',2 ''- terpyridine) is a compound synthesized for this purpose. We investigated its anti-proliferative and pro-apoptotic effects on Ehrlich Ascites Carcinoma (EAC) in vivo. Materials and Methods: 42 Balb-c female mice were subcutaneously (s.c.) injected with EAC cells (1st day) and then randomly divided into 5 groups: control (0.9% NaCl), complex (2 mg/kg), complex (3 mg/kg) cisplatin (4 mg/kg) and paclitaxel (12.5 mg/kg). On the 5th and 12th day animals were drug administrated. At 14th day, animals were sacrificed. Expression of cell death and/or cell cycle-related markers (Bcl-2, Bax, active caspase-3, p53, PCNA) and apoptosis were investigated immunohisto-chemically. Survival-related markers (Akt, GSK-3 beta, IGF-1R, IR, IRS-1, p70S6K, PRAS40) were evaluated by luminex analysis. Results: Expression of p53, PCNA, Bcl-2 was found decreased (p< 0.001) and that of active caspase-3, Bax, and apoptotic cells was found increased (p< 0.001) in all groups. The survivalrelated markers did not show any statistical difference in complex groups. Conclusion: The Pd(II)-complex seems to have a strong anticancer activity on EAC by inducing apoptosis via both suppression of proliferation and activation of apoptosis in vivo, similar to the effects of cisplatin and paclitaxel.
URI: https://iv.iiarjournals.org/content/30/4/457.short
http://hdl.handle.net/11452/29655
ISSN: 0258-851X
1791-7549
Koleksiyonlarda Görünür:Scopus
Web of Science

Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.


DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.